The 11th Asia-Pacific Breast Cancer Summit "Reaching New Height in Breast Cancer Care"
The 11th Asia-Pacific Breast Cancer Summit ”Reaching New Height in Breast Cancer Care” was held in Shangri La Singapore from 4-6 May 2023. Breast cancer experts gathered in Singapore to share insights, update new clinical practices, discovered new trends in the treatment of breast cancer.
Innogene Kalbiotech Pte Ltd participated in the 11th Asia-Pacific Breast Cancer Summit exhibition where we displayed our breast cancer genomic test, MammaPrint and BluePrint. The MammaPrint® test analyzes the 70 most important genes associated with breast cancer recurrence. The BluePrint® test identifies the underlying biology of an individual breast cancer. The tumor is then accurately classified as luminal, basal, HER2 subtypes, which reveal valuable information about its behavior, long-term prognosis and response to systemic therapy.
In collaboration with Agendia, Innogene Kalbiotech Pte Ltd also conducted a Round Table Presentation on "Using MammaPrint + BluePrint to redefines Patient's Outcome in Early Stage Breast Cancer : A Real World Case Study presentation". The speaker, Dr. William Audeh from USA, presented clearly the benefit of MammaPrint and BluePrint in supporting doctors to optimize treatement planning and improve patient outcomes. Several Doctors attended offline and online.